<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:department>MRC Toxicology Unit</gtr:department><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EBABB71C-FC61-4893-95D0-894123374163"><gtr:id>EBABB71C-FC61-4893-95D0-894123374163</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Willis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF018738%2F2"><gtr:id>8D9F4D82-EDE2-484A-8EEF-02DA1DEFD4C8</gtr:id><gtr:title>Enhancing global and mRNA specific translation for improved recombinant protein expression in in vitro cultured mammalian cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F018738/2</gtr:grantReference><gtr:abstractText>Many of the new drugs currently under development are based upon proteins rather than traditional small molecules (e.g. antibiotics). One of the type of protein molecules that is particularly challenging to make are antibodies e.g. herceptin. These protein drugs are produced for the treatment of diseases such as cancer by cells kept in culture under defined conditions. One problem with this is that the cells we use to make proteins for therapeutic uses are not as efficient as we would like them to be and therefore we may not be able to produce enough of these drugs and the cost and demand for them is high. Protein synthesis is the process by which the information in the genetic material in the cell, DNA is converted via an intermediary substrate mRNA, into proteins. For proteins to be synthesised the mRNA must interact with a large complex called the ribosome which consists of RNAs and proteins. Ribosomes are able to decode the genetic information that is held in the mRNA and carry out the synthesis of the proteins. There are two distinct mechanisms by which mRNAs can interact with the ribosomes. The most common mechanism requires the binding of a protein complex to the 5' end of the mRNA and this complex then recruits the ribosome. However, certain mRNAs contain 5' regions that do not code for sections of proteins (termed untranslated regions; UTRs) and these sequences of RNA harbour the information that is required to form a complex RNA structure. These RNA structures allow the ribosome to be recruited to the mRNA generally a considerable distance from the 5' end and so this method of ribosome recruitment has been termed internal ribosome entry. Interestingly, messages that use internal ribosome entry generally encode proteins that are used under situations of cell stress including under temperature reduction (cold-shock). This information is of industrial relevance since the production of commercially valuable proteins (e.g. antibodies) is hindered when cells become stressed later in culture and by the cold-shock that is commonly induced during fermentation. We aim to use the 5' UTRs of mRNAs that are translationally active during cold-shock to enhance the production of proteins that are important to industry. Achieving this is very important as it is expected that with an increasing number of protein 'drugs' being developed we will lack the capability of producing large enough amounts to meet the required demand for these new drugs for the majority, as opposed to for those who can afford what must currently remain prohibitively expensive, but very effective, medicines.</gtr:abstractText><gtr:technicalSummary>The ability of industrially relevant expression systems to produce recombinant protein (rP) has advanced considerably in recent years, however despite such advances our understanding of the cellular processes that determine/limit rP yield from in vitro cultured mammalian cells remains poor. Recent reports suggest that the limitations are at least partially linked to modulation of translation, the mechanism(s) by which mRNAs interact with/are loaded onto ribosomes, mRNA turnover and sequestration, and control elements within the non-coding regions (UTRs) of mRNAs. Despite such reports, whether these control mechanisms can be manipulated to enhance the translation of specific recombinant mRNAs and ultimately enhance rP synthesis under 'normal' (37degC) and sub-physiological (32degC) culture temperatures within the same fermentation in an industrially relevant manner remains open to question. The proposed programme of work will test the hypothesis that via modulation of global translation, over-expression of mRNA chaperones, and by utilising components of the 5' and 3'-UTRs of endogenous mRNAs, recombinant mRNA specific translation can be enhanced in mammalian cells in a controlled and predictable manner to increase rP yields. We will utilise a combination of molecular and protein based approaches to characterise the links between mRNA translation factors and the control of their activity, mRNA chaperones, mRNA UTRs, protein synthesis, and gene expression that are implicated in the cellular responses governing/limiting rP yield. The outcomes will be (i) an understanding of those mechanisms governing recombinant mRNA translation under biphasic temperature culturing conditions of in vitro cultured mammalian cells, (ii) the design of new approaches to modulate global mRNA expression in an industrial context, and (iii) the rational development of plasmid vectors to allow enhanced translation of recombinant mRNAs during bioprocessing.</gtr:technicalSummary><gtr:fund><gtr:end>2011-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>142557</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminar Human Genetics Unit Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E334C7E0-70C8-4C16-89BC-BB79542EA2A6</gtr:id><gtr:impact>MRC Human Genetics Unit, Edinburgh

Interest in work from colleagues</gtr:impact><gtr:outcomeId>CmtziWyEppU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3A630200-73E5-426E-8DF1-0022BF0DDE84</gtr:id><gtr:impact>Gave TV interviews about the Unit's research to ITN, BBC East midlands todays, ITV Central, Sky News and Chanel 5 news.

Huge interest in the Unit's science from the public.</gtr:impact><gtr:outcomeId>S6kHDp4oa4Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar to University of W?rzburg, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>69C08998-36AE-46ED-92BA-5F0C202EEF56</gtr:id><gtr:impact>Research talk stimulated interest

formal collaborations established</gtr:impact><gtr:outcomeId>5458eaba53a8c9.74614762</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brooke Priory school visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F950063B-B595-4CF9-AF24-A7605C91CB7C</gtr:id><gtr:impact>30 children spent a day making DNA in the Unit.
They had 2 lectures one of which I presented

About half the children decided that they would like to be scientists but they were only 10!</gtr:impact><gtr:outcomeId>gZhx4F5z1PD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar Sanquin Research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2D400202-BD64-4E65-8833-A2533D331203</gtr:id><gtr:impact>100 researchers attended talk. Seminar and Masterclass, Sanquin Research &amp;amp; Landsteiner Lab., Amsterdam

new collaborations</gtr:impact><gtr:outcomeId>KePtZtGV8S8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar Queens University Belfast</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>644507D7-B80A-486F-B7CA-1CAA5B6B0247</gtr:id><gtr:impact>September 24 - Centre for Cancer Research &amp;amp; Cell Biology, Queens University, Belfast.

Interest in research area</gtr:impact><gtr:outcomeId>ci1dzfcWt5B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar University of Tor Vergata Rome</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>706ED069-1A69-418D-BFC4-00EB74ABE70A</gtr:id><gtr:impact>Pharmacy Summer School, University of Tor Vergata, Rome

Attended by students who showed interest in the research area</gtr:impact><gtr:outcomeId>f3SkbLQkJq7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar to University of Rome Tor Vergata</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BDFC239F-5A6A-4827-A8A4-0CC160F8A011</gtr:id><gtr:impact>Research seminar, many questions

important new interactions</gtr:impact><gtr:outcomeId>5458e98daf7358.21016112</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>conference Roscoff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0049224B-83C7-4B2D-932D-C47135BBE313</gtr:id><gtr:impact>Talk to colleagues,

new collaborations established</gtr:impact><gtr:outcomeId>tYGqZG9uhDm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar University of Surrey</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9A7ACA06-D490-4B99-A9E5-1776C6D119F4</gtr:id><gtr:impact>May 23 - Dept. of Microbiological &amp;amp; Cellular Sciences, University of Surrey

new collaborations</gtr:impact><gtr:outcomeId>R7J2qsiDuex</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Unit Open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC125CD8-A1A8-4C41-975D-16B09C80D87C</gtr:id><gtr:impact>Over 500 members of the pubic visited the Unit

Member of the public were very appreciative.
Students asked to come and carry out work experience in the Unit</gtr:impact><gtr:outcomeId>AZ2qZmBoiJx</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5D039333-DE31-430C-B080-BF3BF8660A2F</gtr:id><gtr:impact>Lecture on theory of knowledge and how scientific theories are developed to year 11 IB students

Increased appreciation of scientific thought.</gtr:impact><gtr:outcomeId>ZPEjxkrghZQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RNA UK cumbria conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83546AAB-4397-4353-B4E4-259D33F2FF2D</gtr:id><gtr:impact>stimulated interest in our research

Amandine Bastide from my laboratory was awarded a prize for best talk</gtr:impact><gtr:outcomeId>5458df64625da1.92947877</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust collaborative award</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F6B32796-3A37-4359-BB10-8BB81F2D111A</gtr:id><gtr:outcomeId>58c6c618b97ec0.49165638</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Cooling is used in industrial biotechnology to enhance the production of biologically therapeutically relevant proteins such as insulin. We have shown how the overall rate of protein synthesis is affected by cooling and this understanding will help to over come these issues and boost production.</gtr:description><gtr:exploitationPathways>Industry will be able to use our findings to increase protein production in cooled cells.</gtr:exploitationPathways><gtr:id>FF9C4887-FE8C-4853-8107-D4B2EA339B1C</gtr:id><gtr:outcomeId>56de9fc9d7d671.44081979</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CDFA2CCC-D4F1-4D77-A2DF-7EDF837AC2DE</gtr:id><gtr:title>Active regulator of SIRT1 is required for ribosome biogenesis and function.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bb43eadc376abbf6c6d96b46a2f16b0"><gtr:id>2bb43eadc376abbf6c6d96b46a2f16b0</gtr:id><gtr:otherNames>Knight JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>doi_15229_nar_gkt129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9489D7B4-91FA-44FC-97BA-0AA8F0736DEE</gtr:id><gtr:title>ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a341e8703c906448bd76a1d0f9717362"><gtr:id>a341e8703c906448bd76a1d0f9717362</gtr:id><gtr:otherNames>Roobol A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>bn3CMWxaGBK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1755A20D-54FC-4091-B4D6-F9CEC8EC6468</gtr:id><gtr:title>p58IPK is an inhibitor of the eIF2a kinase GCN2 and its localization and expression underpin protein synthesis and ER processing capacity.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a341e8703c906448bd76a1d0f9717362"><gtr:id>a341e8703c906448bd76a1d0f9717362</gtr:id><gtr:otherNames>Roobol A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5458a821ec1db8.87299149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F8DCFEA-FCF4-44B8-907A-6645219F7AD7</gtr:id><gtr:title>Eukaryotic elongation factor 2 kinase regulates the cold stress response by slowing translation elongation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bb43eadc376abbf6c6d96b46a2f16b0"><gtr:id>2bb43eadc376abbf6c6d96b46a2f16b0</gtr:id><gtr:otherNames>Knight JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5458a78ba18d73.97033767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEF01766-A4FD-4C0E-A1C2-CCD7708A40E8</gtr:id><gtr:title>The chaperonin CCT interacts with and mediates the correct folding and activity of three subunits of translation initiation factor eIF3: b, i and h.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a341e8703c906448bd76a1d0f9717362"><gtr:id>a341e8703c906448bd76a1d0f9717362</gtr:id><gtr:otherNames>Roobol A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5458a820e83e26.21142954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41B6E352-4BBE-4716-80D3-E2E0EA2156BD</gtr:id><gtr:title>mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d505f3bed1b9e4c694015f056cbc317"><gtr:id>4d505f3bed1b9e4c694015f056cbc317</gtr:id><gtr:otherNames>Faller WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545c95ba90c668.23203839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F4CF47A-55F8-4D34-8D0C-522F84D54603</gtr:id><gtr:title>RNA binding protein/RNA element interactions and the control of translation.</gtr:title><gtr:parentPublicationTitle>Current protein &amp; peptide science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9713132b92dcd31dc9edc16fb86ed6de"><gtr:id>9713132b92dcd31dc9edc16fb86ed6de</gtr:id><gtr:otherNames>Pichon X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1389-2037</gtr:issn><gtr:outcomeId>pm_15229_29_22708490</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F018738/2</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>9E23F80D-23AC-4055-BBF1-1073215B2D40</gtr:id><gtr:grantRef>BB/F018738/1</gtr:grantRef><gtr:amount>311265.39</gtr:amount><gtr:start>2008-07-06</gtr:start><gtr:end>2010-07-05</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>8D9F4D82-EDE2-484A-8EEF-02DA1DEFD4C8</gtr:id><gtr:grantRef>BB/F018738/2</gtr:grantRef><gtr:amount>142557.59</gtr:amount><gtr:start>2010-07-01</gtr:start><gtr:end>2011-06-30</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>